Known as deep vein thrombosis, blood clots affect the large veins in the lower leg and thigh. They are responsible for killing hundreds of people worldwide, in particular. After joint replacement surgery. If the clot is released and goes into the bloodstream, it can accumulate in the lungs, a condition known as pulmonary embolism that is often fatal.
Treating blood clots with syringes after joint surgery is painful and can cause bleeding. Now, an international team has found a better way to prevent fatal blood clots without increasing the risk of bleeding, the ‘New England Journal of Medicine’ reported.
In a double blind study of more than 3,000 patients, researchers tested a new type of anti-clotting drug called apixaban, an oral drug. The drug proved to be equally effective in preventing blood clots and halved the risk of bleeding. The most important thing for the convenience of the patients is that it was very easy to use, he said. This is a major step in our fight to prevent DVT and many unnecessary deaths due to blood clots occur every year after joint replacement surgery.
“We now have a better treatment that reduces the risk of bleeding, and a patient no longer has to be injected with a needle,” said Gary Raskob, team leader at the University of Oklahoma.